Trifluoroacetic acid → 8-Cyclopropyl-4-(3-imidazol-1-yl-phenyl)-1,3-dihydro-benzo[b][1,4]diazepin-2-one
반응식
C(OC(=O)[NH:7][C:8]1[CH:13]=[CH:12][C:11]([CH:14]2[CH2:16][CH2:15]2)=[CH:10][C:9]=1[NH:17][C:18](=[O:33])[CH2:19][C:20]([C:22]1[CH:27]=[CH:26][CH:25]=[C:24]([N:28]2[CH:32]=[CH:31][N:30]=[CH:29]2)[CH:23]=1)=O)(C)(C)C.C(O)(C(F)(F)F)=O>C(Cl)Cl>[CH:14]1([C:11]2[CH:12]=[CH:13][C:8]3[N:7]=[C:20]([C:22]4[CH:27]=[CH:26][CH:25]=[C:24]([N:28]5[CH:32]=[CH:31][N:30]=[CH:29]5)[CH:23]=4)[CH2:19][C:18](=[O:33])[NH:17][C:9]=3[CH:10]=2)[CH2:16][CH2:15]1참가 물질
4
실험 절차
Prepared from {4-cyclopropyl-2-[3-(3-imidazol-1-yl-phenyl)-3-oxo-propionylamino]-phenyl}-carbamic acid tert.-butyl ester (Example K80) by treatment with TFA in CH2Cl2 according to the general procedure M. Obtained as a light brown solid (41 mg).
출처 및 근거
- ORD 기록
- ord-aa4bc4e5ed1947d8873522a1bd198c53
- 출처 데이터셋
- uspto-grants-2005_11
- 특허 번호
- US06960578B2
반응 노트
불러오는 중…